Overview


According to FutureWise analysis the market for Targeted Liposomes Drug Delivery is expected to register a CAGR of 10.00% from 2024-2032.

A liposome refers to a spherical vessel containing more than one lipid bilayer, and their interaction in an aqueous stage. When the hydrophobic bilayer is constantly repelled by dissolved water molecules, a liposome is created. It can be used to deliver pharmaceutical drugs, mRNA vaccines, and DNA vaccinations. COVID-19 has also made it possible to use liposomes for drug delivery, which helped reduce the socioeconomic burden. Liposomes can be used to treat fungal diseases, pain management, and cancer therapy, as well as for viral vaccines. They have been extensively studied because of their multiple forms, including unilamellar and multi-lamellar lamellar. Liposome drug delivery is a cost-effective way to deliver genomes and vaccines because of its targeted ability and the correct gene inputs. This method has fewer side effects than traditional ones. They are expensive to produce and have poor physical stability, which can hinder the market growth. This is a serious disease that can be fatal if not treated early. Patients with cancer are treated with anticancer drugs. They can either kill cancer cells or incite apoptosis. Liposomal drug formulations can reduce the toxic side effects and efficacy of chemotherapy drugs. Many factors influence the properties of biological compounds. The doxorubicin in the lipids is called pegylated doxorubicin. It is contained in small spheres known as pegylated liposomes. These spheres allow doxorubicin to remain in the bloodstream for longer so that it can reach the cancer cells more effectively. This type of sphere is used to treat breast cancer, ovarian carcinoma, multiple myeloma, and other types.

This market is expected to grow due to the increasing incidence of cancers. The inactivation of B-cell Leukemia 2 protein (Bcl-2), which is an apoptosis inhibitor, induces apoptosis with Liposomal Paclitaxel. The potential for higher paclitaxel delivery to target tissues by using Paclitaxel liposome formulation may increase the effectiveness of the drug. It also has lower systemic toxicities. This type is highly effective and has a high demand. This has led to an increase in this segment. Liposomal Amphotericin A is used to treat various parasitic and fungal infections. This segment is growing due to the increasing number of fungal infections patients. Folate-targeted liposomes and other products are the other segments. The size of liposomal vesicles may range from 0.025 to 2.5um. You can also classify liposomes based on the number of layers they contain. Multilamellars are composed of multiple unilamellar with a length greater than 500nm. Liposome drug delivery can be used for routine clinical practice to increase in vivo and in vitro drug activity. The market for liposome drug delivery is now focusing on drug delivery nanosystems that include major antiviral classes and their transport across specific barriers at both the cellular and intracellular levels.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Targeted Liposomes Drug Delivery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Targeted Liposomes Drug Delivery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Spectrum Pharmaceuticals Inc
  • Astellas Pharma Inc
  • Gilead Sciences Inc
  • Celsion Corporation
  • Ipsen Pharma
  • Pacira BioSciences Inc
  • Luye Pharma Group
  • Novartis AG
  • Johnson and Johnson
  • Takeda Pharmaceutical Company limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Others

By Technology

  • Stealth Liposome Technology
  • Non-PEGylated Liposome Technology
  • DepoFoam Liposome Technology
  • Others

By Application

  • Fungal Diseases
  • Cancer Therapy
  • Pain Technology
  • Viral Vaccines
  • Photodynamic Therapy
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Targeted Liposomes Drug Delivery Market By Product, By Technology, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Targeted Liposomes Drug Delivery Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Targeted Liposomes Drug Delivery Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Targeted Liposomes Drug Delivery Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Targeted Liposomes Drug Delivery Market, By Product Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Liposomal Doxorubicin
        2. Liposomal Paclitaxel
        3. Liposomal Amphotericin B
        4. Others

  • 8.   Targeted Liposomes Drug Delivery Market, By Technology Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Stealth Liposome Technology
        2. Non-PEGylated Liposome Technology
        3. DepoFoam Liposome Technology
        4. Others

  • 9.   Targeted Liposomes Drug Delivery Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Fungal Diseases, Cancer Therapy
        2. Pain Technology
        3. Viral Vaccines
        4. Photodynamic Therapy
        5. Others

  • 10.   North America Targeted Liposomes Drug Delivery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.   Latin America Targeted Liposomes Drug Delivery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.   Europe Targeted Liposomes Drug Delivery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.   Asia Pacific Targeted Liposomes Drug Delivery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.   Middle East and Africa Targeted Liposomes Drug Delivery Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Spectrum Pharmaceuticals Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Astellas Pharma Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Gilead Sciences Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Celsion Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Ipsen Pharma
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Pacira BioSciences Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Luye Pharma Group
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Novartis AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Johnson and Johnson
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Takeda Pharmaceutical Company limited
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients